Ovid Therapeutics Inc Share Price Today: Live Updates & Key Insights

Ovid Therapeutics Inc share price today is $2.614, up 13.91%. The stock opened at $2.35 against the previous close of $2.3, with an intraday high of $2.715 and low of $2.35.

Ovid Therapeutics Inc Share Price Chart

Ovid Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Ovid Therapeutics Inc Share Price Performance

$2.614 0.1391(13.91%) OVID at 23 Mar 2026 02:38 PM Biotechnology
Lowest Today 2.35
Highest Today 2.715
Today’s Open 2.35
Prev. Close 2.3
52 Week High 2.72
52 Week Low 0.24
Day’s Range: Low 2.35 High 2.715
52-Week Range: Low 0.24 High 2.72
1 day return -
1 Week return +34.44
1 month return +80.34
3 month return +47.74
6 month return +101.15
1 year return +498.12
3 year return +7.61
5 year return -39.04
10 year return -

Ovid Therapeutics Inc Institutional Holdings

RA Capital Management, LLC 15.05

Takeda Pharmaceutical Co Ltd 10.58

Affinity Asset Advisors, LLC 10.04

ADAR1 Capital Management LLC 6.02

Eventide Asset Management, LLC 6.02

Eventide Healthcare & Life Sciences I 6.02

Federated Hermes Kaufmann Small Cap A 5.01

Adage Capital Partners Gp LLC 4.90

Vanguard Group Inc 4.31

Saturn V Capital Management LLC 3.51

Acadian Asset Management LLC 3.21

Vanguard Total Stock Mkt Idx Inv 2.82

Ally Bridge Group (NY) LLC 2.51

Renaissance Technologies Corp 2.08

Sio Capital Management, LLC 2.00

Millennium Management LLC 1.88

Marshall Wace Asset Management Ltd 1.79

Ikarian Capital, LLC 1.54

Awm Investment Company Inc 1.26

Jane Street Group LLC 1.24

Citadel Advisors Llc 1.12

Wells Fargo & Co 1.03

Geode Capital Management, LLC 0.94

Vanguard Institutional Extnd Mkt Idx Tr 0.87

Fidelity Extended Market Index 0.45

Blackrock Extended Mkt Fund CF 0.21

Extended Equity Market Fund K 0.18

Fidelity Total Market Index 0.16

NT Ext Equity Mkt Idx Fd - L 0.14

EA Bridgeway Omni Small-Cap Value ETF 0.13

Fidelity Series Total Market Index 0.12

Spartan Extended Market Index Pool F 0.11

NT Ext Equity Mkt Idx Fd - NL 0.09

Northern Trust Extended Eq Market Idx 0.09

Vanguard Instl Ttl Stck Mkt Idx Tr 0.08

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

Spartan Total Market Index Pool G 0.07

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.05

Invesco NASDAQ Future Gen 200 ETF 0.05

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.05

Ovid Therapeutics Inc Market Status

Strong Buy: 5

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Ovid Therapeutics Inc Fundamentals

Market Cap 186.58 M

PB Ratio 4.1742

PE Ratio 0.0

Enterprise Value 174.74 M

Total Assets 150.93 M

Volume 10114724

Ovid Therapeutics Inc Company Financials

Annual Revenue FY23:296412 0.3M, FY22:1502748 1.5M, FY21:208382779 208.4M, FY20:12617221 12.6M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:1502748 1.5M, FY21:208382779 208.4M, FY20:12617221 12.6M, FY19:null 0.0M

Annual Net worth FY23:-48521714 -48.5M, FY22:-51408292 -51.4M, FY21:122834584 122.8M, FY20:-80728728 -80.7M, FY19:-59258017 -59.3M

Quarterly Revenue Q3/2025:132000 0.1M, Q2/2025:6272000 6.3M, Q1/2025:130000 0.1M, Q3/2024:173000 0.2M, Q2/2024:169000 0.2M

Quarterly Profit Q3/2025:115000 0.1M, Q2/2025:6272000 6.3M, Q1/2025:130000 0.1M, Q3/2024:173000 0.2M, Q2/2024:21000 0.0M

Quarterly Net worth Q3/2025:-12158000 -12.2M, Q2/2025:-4684000 -4.7M, Q1/2025:-10235000 -10.2M, Q3/2024:-14006000 -14.0M, Q2/2024:8521000 8.5M

About Ovid Therapeutics Inc & investment objective

Company Information Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Organisation Biotechnology

Employees 23

Industry Biotechnology

CEO Ms. Margaret Alexander

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Ovid Therapeutics Inc FAQs

What is the share price of Ovid Therapeutics Inc today?

The current share price of Ovid Therapeutics Inc is $2.614.

Can I buy Ovid Therapeutics Inc shares in India?

Yes, Indian investors can buy Ovid Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Ovid Therapeutics Inc shares in India?

You can easily invest in Ovid Therapeutics Inc shares from India by:

Can I buy fractional shares of Ovid Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Ovid Therapeutics Inc?

Ovid Therapeutics Inc has a market cap of $186.58 M.

In which sector does Ovid Therapeutics Inc belong?

Ovid Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Ovid Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Ovid Therapeutics Inc?

The PE ratio of Ovid Therapeutics Inc is N/A and the PB ratio is 4.17.